5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 38.00▼ | 34.50▲ |
MA10 | N/A | N/A | N/A | 38.05▼ | 32.00▲ |
MA20 | N/A | N/A | N/A | 33.60▲ | 32.01▲ |
MA50 | N/A | N/A | N/A | 31.17▲ | 37.28▼ |
MA100 | N/A | N/A | N/A | 31.69▲ | 34.78▲ |
MA200 | N/A | N/A | N/A | 37.00▼ | 31.45▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 0.332▲ | 1.304▲ |
RSI | N/A | N/A | N/A | 69.215▲ | 56.445▲ |
STOCH | N/A | N/A | N/A | 66.800 | 57.282 |
WILL %R | N/A | N/A | N/A | -29.740 | -27.778 |
CCI | N/A | N/A | N/A | 34.530 | 148.053▲ |
CDL | $ALT.L Doji Candlestick Pattern Detected | Set Alert |
Tuesday, May 14, 2024 08:59 AM
Altimmune ( NASDAQ:ALT ) First Quarter 2024 Results Key Financial Results Net loss: US$24.4m (loss widened by 22% from... Enrollment ongoing in IMPACT Phase 2b trial of pemvidutide in Metabolic ...
|
Tuesday, May 14, 2024 08:59 AM
Altimmune ( NASDAQ:ALT ) First Quarter 2024 Results Key Financial Results Net loss: US$24.4m (loss widened by 22% from... Enrollment ongoing in IMPACT Phase 2b trial of pemvidutide in Metabolic ...
|
Wednesday, May 01, 2024 04:25 AM
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/05/24 | 37.00 | 37.98 | 37.00 | 37.00 | 10,872 |
14/05/24 | 37.95 | 37.95 | 37.00 | 37.00 | 56,525 |
13/05/24 | 38.25 | 38.25 | 37.603 | 38.00 | 132,737 |
10/05/24 | 39.00 | 39.00 | 38.50 | 39.00 | 37,240 |
09/05/24 | 39.00 | 39.00 | 38.402 | 39.00 | 2,619 |
08/05/24 | 39.00 | 39.00 | 38.22 | 39.00 | 37,515 |
07/05/24 | 39.50 | 40.40 | 38.00 | 39.00 | 262,288 |
03/05/24 | 36.77 | 41.00 | 36.77 | 39.50 | 320,177 |
02/05/24 | 36.00 | 37.00 | 35.20 | 36.50 | 135,750 |
01/05/24 | 34.03 | 37.48 | 34.03 | 36.50 | 966,217 |
|
|
||||
|
|
||||
|
|